{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T06:40:52Z","timestamp":1770964852998,"version":"3.50.1"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,2]],"date-time":"2019-02-02T00:00:00Z","timestamp":1549065600000},"content-version":"am","delay-in-days":338,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases of the National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI111159"],"award-info":[{"award-number":["R21AI111159"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH-NIGMS-RISE","doi-asserted-by":"publisher","award":["1R25GM106995-01"],"award-info":[{"award-number":["1R25GM106995-01"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation (NSF)-CREST","doi-asserted-by":"publisher","award":["HRD-1241701"],"award-info":[{"award-number":["HRD-1241701"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P30 AI027767"],"award-info":[{"award-number":["P30 AI027767"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.biomaterials.2017.12.019","type":"journal-article","created":{"date-parts":[[2017,12,26]],"date-time":"2017-12-26T05:28:42Z","timestamp":1514266122000},"page":"130-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Caveolin-mediated endocytosis of the Chlamydia M278 outer membrane peptide encapsulated in poly(lactic acid)-Poly(ethylene glycol) nanoparticles by mouse primary dendritic cells enhances specific immune effectors mediated by MHC class II and CD4+ T cells"],"prefix":"10.1016","volume":"159","author":[{"given":"Saurabh","family":"Dixit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajnish","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richa","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Skyla","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo H.","family":"Giambartolomei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shree R.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vida A.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2017.12.019_bib1","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.nano.2014.02.009","article-title":"Poly(lactic acid)-poly(ethylene glycol) nanoparticles provide sustained delivery of a Chlamydia trachomatis recombinant MOMP peptide and potentiate systemic adaptive immune responses in mice","volume":"10","author":"Dixit","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biomaterials.2017.12.019_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ymeth.2006.05.018","article-title":"Methods for nano-particle based vaccine formulation and evaluation of their immunogenicity","volume":"40","author":"Kalkanidis","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.biomaterials.2017.12.019_bib3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/156652407780059140","article-title":"Designing recombinant vaccines with viral properties: a rational approach to more effective vaccines","volume":"7","author":"Jennings","year":"2007","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i1.20","article-title":"Recent developments of biodegradable and biocompatible materials based micro\/nanoparticles for delivering macromolecular therapeutics","volume":"26","author":"Shi","year":"2009","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1126\/science.1069784","article-title":"Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae","volume":"296","author":"Pelkmans","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2017.12.019_bib7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1042\/BJ20080474","article-title":"Focusing on clathrin-mediated endocytosis","volume":"412","author":"Rappoport","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib8","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/smll.201100442","article-title":"More effective nanomedicines through particle design","volume":"7","author":"Wang","year":"2011","journal-title":"Small (Weinheim an der Bergstrasse, Germany)"},{"key":"10.1016\/j.biomaterials.2017.12.019_bib9","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1021\/nn9012274","article-title":"Size and dynamics of caveolae studied using nanoparticles in living endothelial cells","volume":"3","author":"Wang","year":"2009","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2017.12.019_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.addr.2012.09.041","article-title":"Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances","volume":"65","author":"Xu","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib11","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jconrel.2014.06.038","article-title":"Insight into nanoparticle cellular uptake and intracellular targeting","volume":"190","author":"Yameen","year":"2014","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.biomaterials.2017.12.019_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/pr.58.1.8","article-title":"Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery","volume":"58","author":"Khalil","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nchembio.1391","article-title":"A\u00a0peptide's perspective on antigen presentation to the immune system","volume":"9","author":"Neefjes","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib14","first-page":"1","article-title":"The endocytosis and intracellular fate of nanomedicines: implication for rational design","volume":"8","author":"Kou","year":"2013","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymeth.2006.05.016","article-title":"Pathogen recognition and development of particulate vaccines: does size matter?","volume":"40","author":"Xiang","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.biomaterials.2017.12.019_bib16","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1016\/j.biomaterials.2007.08.015","article-title":"Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response","volume":"28","author":"Kanchan","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2017.12.019_bib17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","article-title":"Nanoparticle vaccines","volume":"32","author":"Zhao","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2017.12.019_bib18","first-page":"1759","article-title":"Formulation, characterization, and expression of a recombinant MOMP Chlamydia trachomatis DNA vaccine encapsulated in chitosan nanoparticles","volume":"8","author":"Cambridge","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib19","first-page":"2085","article-title":"Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine","volume":"8","author":"Fairley","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib20","doi-asserted-by":"crossref","first-page":"325101","DOI":"10.1088\/0957-4484\/23\/32\/325101","article-title":"Biodegradable PLGA85\/15 nanoparticles as a delivery vehicle for Chlamydia trachomatis recombinant MOMP-187 peptide","volume":"23","author":"Taha","year":"2012","journal-title":"Nanotechnology"},{"key":"10.1016\/j.biomaterials.2017.12.019_bib21","series-title":"Isolation of Dendritic Cells. Current Protocols in Immunology","author":"Inaba","year":"2009"},{"key":"10.1016\/j.biomaterials.2017.12.019_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015263","article-title":"A\u00a0method for generation of bone marrow-derived macrophages from cryopreserved mouse bone marrow cells","volume":"5","author":"Marim","year":"2010","journal-title":"PLos One"},{"key":"10.1016\/j.biomaterials.2017.12.019_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043860","article-title":"Different patterns of expression and of IL-10 modulation of inflammatory mediators from macrophages of Lyme disease-resistant and -susceptible mice","volume":"7","author":"Gautam","year":"2012","journal-title":"PLos One"},{"key":"10.1016\/j.biomaterials.2017.12.019_bib24","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1073\/pnas.1322356111","article-title":"Differential uptake of nanoparticles by endothelial cells through polyelectrolytes with affinity for caveolae","volume":"111","author":"Voigt","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2017.12.019_bib25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.femsim.2005.02.010","article-title":"Infection of epithelial and dendritic cells by Chlamydia trachomatis results in IL-18 and IL-12 production, leading to interferon-gamma production by human natural killer cells","volume":"45","author":"Hook","year":"2005","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib26","doi-asserted-by":"crossref","first-page":"6798","DOI":"10.1128\/IAI.68.12.6798-6806.2000","article-title":"Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes","volume":"68","author":"Igietseme","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib27","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1440-1711.2005.01365.x","article-title":"Differential expression of inflammatory chemokines by Th1- and Th2-cell promoting dendritic cells: a role for different mature dendritic cell populations in attracting appropriate effector cells to peripheral sites of inflammation","volume":"83","author":"Lebre","year":"2005","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib28","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.4049\/jimmunol.164.9.4507","article-title":"Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction","volume":"164","author":"Vieira","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib29","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1046\/j.1523-1747.1999.00769.x","article-title":"Granulocyte-macrophage colony-stimulating factor gene transfer to dendritic cells or epidermal cells augments their antigen-presenting function including induction of anti-tumor immunity","volume":"113","author":"Ozawa","year":"1999","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","article-title":"Chemokines and chemokine receptors: positioning cells for host defense and immunity","volume":"32","author":"Griffith","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib31","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1128\/iai.63.12.4661-4668.1995","article-title":"Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection","volume":"63","author":"Morrison","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/femsle\/fnw170","article-title":"The role of NOD1 and NOD2 in host defense against chlamydial infection","volume":"363","author":"Zou","year":"2016","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1515\/hsz-2013-0220","article-title":"Lipid antigens in immunity","volume":"395","author":"Dowds","year":"2014","journal-title":"Biol. Chem."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib34","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1128\/IAI.66.4.1282-1286.1998","article-title":"Chlamydial infection in inducible nitric oxide synthase knockout mice","volume":"66","author":"Igietseme","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.immuni.2013.12.013","article-title":"Toll-like receptor and inflammasome signals converge to amplify the innate bactericidal capacity of T helper 1 cells","volume":"40","author":"O'Donnell","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2017.12.019_bib36","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0952-7915(02)00361-8","article-title":"The role of IFN-gamma in the outcome of chlamydial infection","volume":"14","author":"Rottenberg","year":"2002","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib37","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/cr.2010.19","article-title":"Endocytosis unplugged: multiple ways to enter the cell","volume":"20","author":"Kumari","year":"2010","journal-title":"Cell Res."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib38","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.2217\/nnm-2016-0195","article-title":"Endocytosis and intracellular processing of nanoparticles in dendritic cells: routes to effective immunonanomedicines","volume":"11","author":"Tonigold","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biomaterials.2017.12.019_bib39","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2017.05.028","article-title":"PEG-PCL-based nanomedicines: a biodegradable drug delivery system and its application","volume":"260","author":"Grossen","year":"2017","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.biomaterials.2017.12.019_bib40","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3389\/fmicb.2017.01411","article-title":"Immunization with recombinant TcdB-encapsulated nanocomplex induces protection against Clostridium difficile challenge in a mouse model","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib41","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1128\/IAI.67.4.1763-1769.1999","article-title":"Interleukin-12 production is required for chlamydial antigen-pulsed dendritic cells to induce protection against live Chlamydia trachomatis infection","volume":"67","author":"Lu","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib42","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1128\/IAI.00161-13","article-title":"Contribution of interleukin-12 p35 (IL-12p35) and IL-12p40 to protective immunity and pathology in mice infected with Chlamydia muridarum","volume":"81","author":"Chen","year":"2013","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib43","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1128\/CMR.00105-13","article-title":"Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research","volume":"27","author":"Vasilevsky","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib44","doi-asserted-by":"crossref","first-page":"7368","DOI":"10.1074\/jbc.M610754200","article-title":"CD1d degradation in Chlamydia trachomatis-infected epithelial cells is the result of both cellular and chlamydial proteasomal activity","volume":"282","author":"Kawana","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib45","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.4049\/jimmunol.175.5.3197","article-title":"T\u00a0cell activation promotes Chlamydia trachomatis infection in\u00a0vivo","volume":"175","author":"Bilenki","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047487","article-title":"Interruption of CXCL13-CXCR5 axis increases upper genital tract pathology and activation of NKT cells following chlamydial genital infection","volume":"7","author":"Jiang","year":"2012","journal-title":"PLos One"},{"key":"10.1016\/j.biomaterials.2017.12.019_bib47","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0022-1759(00)00351-3","article-title":"Exogenous antigen targeted to FcgammaRI on myeloid cells is presented in association with MHC class I","volume":"248","author":"Wallace","year":"2001","journal-title":"J.\u00a0Immunol. Meth."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib48","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1086\/377134","article-title":"Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens","volume":"188","author":"Moore","year":"2003","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib49","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1074-7613(02)00294-7","article-title":"FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection","volume":"16","author":"Ioan-Facsinay","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2017.12.019_bib50","first-page":"78","article-title":"Chlamydial lipoproteins stimulate toll-like receptors 1\/2 mediated inflammatory responses through myd88-dependent pathway","volume":"8","author":"Wang","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib51","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/IAI.01062-12","article-title":"Toll-like receptor 2-dependent activity of native major outer membrane protein proteosomes of Chlamydia trachomatis","volume":"81","author":"Massari","year":"2013","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/f3aa682e-3bc2-4a05-ac7f-05c6cfe1bbd7","article-title":"The NOD\/RIP2 pathway is essential for host defenses against Chlamydophila pneumoniae lung infection","volume":"5","author":"Shimada","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039460","article-title":"TLR2, but not TLR4, is required for effective host defence against Chlamydia respiratory tract infection in early life","volume":"7","author":"Beckett","year":"2012","journal-title":"PLos One"},{"key":"10.1016\/j.biomaterials.2017.12.019_bib54","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1462-5822.2006.00686.x","article-title":"Stimulation of the cytosolic receptor for peptidoglycan, Nod1, by infection with Chlamydia trachomatis or Chlamydia muridarum","volume":"8","author":"Welter-Stahl","year":"2006","journal-title":"Cell Microbiol."},{"issue":"11","key":"10.1016\/j.biomaterials.2017.12.019_bib55","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1128\/IAI.00749-16","article-title":"IFNgamma is required for optimal antibody-mediated immunity against genital Chlamydia infection","volume":"84","author":"Naglak","year":"2016","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib56","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.4049\/jimmunol.1002596","article-title":"Chlamydia-specific CD4 T cell clones control Chlamydia muridarum replication in epithelial cells by nitric oxide-dependent and -independent mechanisms","volume":"185","author":"Jayarapu","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib57","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.4049\/jimmunol.1103032","article-title":"CD4+ T cells are necessary and sufficient to confer protection against Chlamydia trachomatis infection in the murine upper genital tract","volume":"189","author":"Gondek","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib58","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1128\/iai.65.6.2145-2152.1997","article-title":"Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice","volume":"65","author":"Cotter","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib59","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3782::AID-IMMU3782>3.0.CO;2-B","article-title":"IFN-gamma knockout mice show Th2-associated delayed-type hypersensitivity and the inflammatory cells fail to localize and control chlamydial infection","volume":"29","author":"Wang","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib60","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1128\/IAI.01378-15","article-title":"Tissue-resident T cells as the central paradigm of Chlamydia immunity","volume":"84","author":"Johnson","year":"2016","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib61","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00409-17","article-title":"Neutrophils are central to antibody-mediated protection against genital Chlamydia","volume":"85","author":"Naglak","year":"2017","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib62","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1128\/iai.62.11.5195-5197.1994","article-title":"Role for CD8+ T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones","volume":"62","author":"Igietseme","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib63","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.4049\/jimmunol.1402675","article-title":"Protective immunity against Chlamydia trachomatis can engage both CD4+ and CD8+ T cells and bridge the respiratory and genital mucosae","volume":"194","author":"Nogueira","year":"2015","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003707","article-title":"B\u00a0cells enhance antigen-specific CD4 T cell priming and prevent bacteria dissemination following Chlamydia muridarum genital tract infection","volume":"9","author":"Li","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib65","doi-asserted-by":"crossref","first-page":"12069","DOI":"10.1073\/pnas.0603866103","article-title":"Monitoring the T cell response to genital tract infection","volume":"103","author":"Roan","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2017.12.019_bib66","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/mi.2010.58","article-title":"CXCR3 and CCR5 are both required for T cell-mediated protection against C. trachomatis infection in the murine genital mucosa","volume":"4","author":"Olive","year":"2011","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib67","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaa8205","article-title":"VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells","volume":"348","author":"Stary","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2017.12.019_bib68","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1211\/jpp.58.6.0002","article-title":"Particulate delivery systems for vaccines: what can we expect?","volume":"58","author":"Bramwell","year":"2006","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib69","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/excr.2001.5202","article-title":"Association of caveolin with Chlamydia trachomatis inclusions at early and late stages of infection","volume":"266","author":"Norkin","year":"2001","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib70","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0014-4827(03)00059-4","article-title":"Lipid rafts, caveolae, caveolin-1, and entry by Chlamydiae into host cells","volume":"287","author":"Stuart","year":"2003","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib71","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2334-4-23","article-title":"Caveolin-2 associates with intracellular chlamydial inclusions independently of caveolin-1","volume":"4","author":"Webley","year":"2004","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.biomaterials.2017.12.019_bib72","series-title":"Models of Immunity","author":"Rank","year":"1999"},{"key":"10.1016\/j.biomaterials.2017.12.019_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines4040034","article-title":"Biodegradable polymeric nanoparticles-based vaccine adjuvants for lymph nodes targeting","volume":"4","author":"Gutjahr","year":"2016","journal-title":"Vaccines"},{"key":"10.1016\/j.biomaterials.2017.12.019_bib74","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/35074539","article-title":"Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER","volume":"3","author":"Pelkmans","year":"2001","journal-title":"Nat. Cell Biol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961217308256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961217308256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:31:08Z","timestamp":1758904268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961217308256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":74,"alternative-id":["S0142961217308256"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2017.12.019","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Caveolin-mediated endocytosis of the Chlamydia M278 outer membrane peptide encapsulated in poly(lactic acid)-Poly(ethylene glycol) nanoparticles by mouse primary dendritic cells enhances specific immune effectors mediated by MHC class II and CD4+ T cells","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2017.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}